Seres Therapeutics Inc (MCRB) — Cash Flow Reinvestment Rate
Seres Therapeutics Inc (MCRB) has a Cash Flow Reinvestment Rate of 0.01x as of September 2025, reinvesting $16.00K (capex $8.00K plus investments $-8.00K) from operating cash flow of $2.21 Million. See Seres Therapeutics Inc (MCRB) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Seres Therapeutics Inc Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Seres Therapeutics Inc across 3 annual periods. For the full cash flow conversion analysis, see Seres Therapeutics Inc (MCRB) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Seres Therapeutics Inc (2016–2025)
Year-by-year capital reinvestment analysis for Seres Therapeutics Inc. See MCRB FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.23x | $252.00K | $1.12 Million | $252.00K | ▼ -98.2% |
| 2021 | 12.44x | $83.22 Million | $6.69 Million | $9.57 Million | ▲ +733.2% |
| 2016 | 1.49x | $65.59 Million | $43.92 Million | $21.49 Million | — |